国际标准期刊号: 2161-0681

临床与实验病理学杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 期刊目录
  • 乌尔里希的期刊目录
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Recent Advances towards Understanding the Role of Opioid Receptor Phosphorylation

Daccache G and Allouche S

 

Opioid receptors, including mu (MOR for mu-opioid receptor), delta (DOR for delta-opioid receptor) and kappa (KOR for kappaopioid receptor), belong to the super family of G-protein coupled receptors (GPCRs). Those receptors, and particularly the MOR, are involved in pain control and are the targets of numerous drugs including morphine and its derivatives. The different opioid receptors are widely and differentially distributed throughout the human central nervous system and peripheral tissues [1]. Molecular studies revealed that MOR and DOR are highly expressed in brain regions with subtle differences; DOR are found at higher levels compared to MOR in cerebral cortex, putamen, nucleus accumbens, caudate nucleus, temporal lobe, and hippocampus. The cerebral distribution of DOR is in agreement with their involvement in motor as well as in cognitive functions. In contrast, higher levels of MOR are measured in cerebellum, the spinal cord and dorsal root ganglia suggesting that they may play an important role in the control of nociception. KOR are expressed in different brain regions although at moderate amounts and are implicated

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。